Avet Pharmaceuticals Inc.
Tushar Bhatt is currently working as a Q.A Group Leader in the Data Auditing & Review group at Avet Pharmaceuticals since March 2020. Prior to this role, Tushar was the R&D Auditor at Zudus Cadila Healthcare Limited from July 1979 to May 2016, where Tushar held the title of Ex General Manager ADLab.
This person is not in any offices
Avet Pharmaceuticals Inc.
Avet Pharmaceuticals Inc. is a rapidly growing generic pharmaceutical company engaged in the acquisition, licensing, development, marketing, sale and distribution of generic pharmaceutical products for the global prescription drug markets. Avet Pharmaceuticals provides high quality generic medicines that help patients and practitioners achieve affordable healthcare solutions. Our global supply chain network is built around centers of manufacturing and scientific excellence to provide you with the highest level of quality, safety, value and service in generics. Our drug portfolio consists of numerous products across a wide range of therapeutic categories, including: cardiovascular, oncology, metabolic disease, anti-infective, infusion and pain management. We are focused on widely utilized, established products as well as niche, high barrier-to-entry products that have limited competition and long life cycles.